Trademark Overview
On Tuesday, June 16, 2026, a trademark application was filed for FREVOYZA with the United States Patent and Trademark Office. The USPTO has given the FREVOYZA trademark a serial number of 99887676. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 16, 2026. This trademark is owned by Takeda Pharmaceuticals International AG. The FREVOYZA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing medical information to patients and healthcare professionals relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; Patient support program providing disease awareness and disease management information and materials to patients and caregivers about pharmaceuticals; providing a related pharmaceutical support program website featuring all of the above; pharmaceutical patient support program providing pharmaceutical usage training and information about access to pharmaceutical products; Providing healthcare information and advice for healthcare professionals
